ALK and lung cancer: Shortly after, Maddalo et al. and Blasco et al. used an in vivo somatic approach to engineer mouse models carrying Eml4-Alk (inversion) fusion-driven lung cancers via intratracheal instillation of recombinant adenoviruses (Maddalo et al., 2014; Blasco et al., 2014).